Diagnostic Imaging to Evaluate TEER Therapy for Heart Failure Patients by Dr. Dee Dee Wang

Dee Dee Wang, MD, FACC, FASE, FSCCT, FSCAI of Henry Ford Health System presents Diagnostic Imaging to Evaluate Transcatheter Edge-to-Edge Repair (TEER) Therapy for Heart Failure Patients during the MISHC Collaborative Meeting on June 28th, 2023.
The Michigan Structural Heart Consortium (MISHC) is a collaboration between the Michigan Society of Thoracic and Cardiovascular Surgeons (MSTCVS) and Michigan Cardiovascular Consortium (BMC2). MISHC is a quality improvement network designed to improve quality of care and outcomes in patients who undergo structural heart procedures, including transcatheter aortic valve replacement, mitral valve replacement, and mitral valve repair procedures.
More information at mishc.org.
Support for MISHC is provided by Blue Cross and Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. Although Blue Cross Blue Shield of Michigan and MISHC work collaboratively, the opinions, beliefs, and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.